138 related articles for article (PubMed ID: 7944508)
1. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma.
Kikuchi K; Sato S; Kadono T; Ihn H; Takehara K
Arch Dermatol; 1994 Oct; 130(10):1269-72. PubMed ID: 7944508
[TBL] [Abstract][Full Text] [Related]
2. Serum concentration of procollagen type I carboxyterminal propeptide in systemic sclerosis.
Kikuchi K; Ihn H; Sato S; Igarashi A; Soma Y; Ishibashi Y; Takehara K
Arch Dermatol Res; 1994; 286(2):77-80. PubMed ID: 8154928
[TBL] [Abstract][Full Text] [Related]
3. The value of serum carboxyterminal propeptide of type 1 procollagen in predicting bone metastases in prostate cancer.
Nakashima J; Sumitomo M; Miyajima A; Jitsukawa S; Saito S; Tachibana M; Murai M
J Urol; 1997 May; 157(5):1736-9. PubMed ID: 9112516
[TBL] [Abstract][Full Text] [Related]
4. Serum aminoterminal propeptide of type III procollagen in progressive systemic sclerosis and localized scleroderma.
Zachariae H; Halkier-Sørensen L; Heickendorff L
Acta Derm Venereol; 1989; 69(1):66-70. PubMed ID: 2563612
[TBL] [Abstract][Full Text] [Related]
5. Elevated procollagen type I carboxyterminal propeptide production in cultured scleroderma fibroblasts.
Kikuchi K; Kadono T; Fujimoto M; Ihn H; Sato S; Takehara K
Dermatology; 1995; 190(2):104-8. PubMed ID: 7727830
[TBL] [Abstract][Full Text] [Related]
6. Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.
Mimra Y; Ihn H; Jinnin M; Asano Y; Yamane K; Yazawa N; Tamaki K
Int J Dermatol; 2005 Oct; 44(10):817-20. PubMed ID: 16207181
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.
Nagaoka T; Sato S; Hasegawa M; Ihn H; Takehara K
J Rheumatol; 2000 Aug; 27(8):1917-21. PubMed ID: 10955333
[TBL] [Abstract][Full Text] [Related]
8. [Measurements and clinical usefulness of carboxyterminal propeptide of type I collagen and cross-linked carboxyterminal telopeptide of type I collagen in patients with prostate cancer].
Igawa T; Sakai H; Kanetake H; Saito Y
Hinyokika Kiyo; 1999 Apr; 45(4):235-9. PubMed ID: 10363141
[TBL] [Abstract][Full Text] [Related]
9. Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma.
Hayakawa I; Hasegawa M; Takehara K; Sato S
Arthritis Rheum; 2004 Jan; 50(1):227-32. PubMed ID: 14730620
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.
Tomimura S; Ogawa F; Iwata Y; Komura K; Hara T; Muroi E; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
J Dermatol Sci; 2008 Oct; 52(1):47-54. PubMed ID: 18565735
[TBL] [Abstract][Full Text] [Related]
12. Antigen specificity of antihistone antibodies in localized scleroderma.
Sato S; Fujimoto M; Ihn H; Kikuchi K; Takehara K
Arch Dermatol; 1994 Oct; 130(10):1273-7. PubMed ID: 7524451
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factor isotypes in localized scleroderma.
Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
Clin Exp Dermatol; 2005 Jul; 30(4):405-8. PubMed ID: 15953082
[TBL] [Abstract][Full Text] [Related]
14. [Measurement of serum concentration with radioimmunoassay for carboxyterminal propeptide of type 1 procollagen].
Yamamoto I; Takada M; Ohnaka Y; Yuu I; Yamamoto Y; Hamazu H; Morita R
Kaku Igaku; 1993 May; 30(5):563-9. PubMed ID: 8336416
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of manganese superoxide dismutase in patients with localized scleroderma.
Jinnin M; Ihn H; Yazawa N; Asano Y; Yamane K; Tamaki K
Exp Dermatol; 2004 Jun; 13(6):357-60. PubMed ID: 15186321
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of type I and III collagen and hyaluronan in scleroderma skin.
Søndergaard K; Heickendorff L; Risteli L; Risteli J; Zachariae H; Stengaard-Pedersen K; Deleuran B
Br J Dermatol; 1997 Jan; 136(1):47-53. PubMed ID: 9039294
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of soluble CD30 are increased in patients with localized scleroderma and correlated with serological and clinical features of the disease.
Ihn H; Yazawa N; Kubo M; Yamane K; Sato S; Fujimoto M; Kikuchi K; Soma Y; Tamaki K
J Rheumatol; 2000 Mar; 27(3):698-702. PubMed ID: 10743811
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
Falanga V; Medsger TA; Reichlin M
Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
[TBL] [Abstract][Full Text] [Related]
19. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
[TBL] [Abstract][Full Text] [Related]
20. Serum levels of carboxy-terminal propeptide of human type I procollagen are an indicator for the progression of diabetic nephropathy in patients with type 2 diabetes mellitus.
Inukai T; Fujiwara Y; Tayama K; Aso Y; Takemura Y
Diabetes Res Clin Pract; 2000 Apr; 48(1):23-8. PubMed ID: 10704696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
